Browndove Healthcare Private Limited (Browndove), a prominent provider of advanced blood transfusion and dialysis-related products in India, partnered with Somerset Indus Healthcare Fund I (Mauritius) (Somerset) for its Series-A investment of INR 170 million (approximately US$3 million). Majmudar & Partners acted as the legal advisor to Browndove and its promoters, ensuring a legally compliant and smooth transaction.

Facilitating the Transaction

Majmudar & Partners assisted in structuring and executing the Series-A investment by:

• Drafting and Negotiating the Investment Agreements: Assisted in preparing and negotiating the share subscription agreement and shareholders’ agreement to align with the interests of Browndove and Somerset.
• Due Diligence Review: Provided comprehensive support to Browndove in addressing legal, regulatory, and compliance issues identified during the investor’s due diligence process.
• Corporate Restructuring Advice: Recommended and implemented corporate restructuring measures to facilitate the investment while ensuring compliance with applicable Indian laws.
• Regulatory Approvals: Guided the client in obtaining requisite regulatory approvals, including compliance with the Companies Act, 2013, and India’s foreign investment regulations.

This Series-A investment enabled Browndove to scale its operations and strengthen its position in the healthcare industry. Majmudar & Partners’ expert handling of legal and regulatory aspects ensured a seamless transaction, fostering a productive partnership between Browndove and Somerset.

Majmudar & Partners excels in facilitating private equity investments with tailored legal solutions. Reach out to us for your investment advisory needs and experience streamlined, efficient deal execution.